Acute Monocytic Leukemia (AML-M5)

All Ages · Both Sexes · All Stages

5-year relative survival

25%for this source population

95% confidence interval 23.7%–26.2%

All Ages · Both Sexes · All Stages

Relative survivalYears after diagnosis

Selected population 5-year: 25%

Shading: selected population’s 95% confidence interval. Lines connect published annual estimates.

SEER · 2000-2022 diagnoses

A population estimate, not a personal forecast.

Source population: Acute Monocytic Leukemia (AML-M5)Captured September 2026 · Research preview